APLS
Apellis Pharmaceuticals Inc
Price:  
41.03 
USD
Volume:  
68,599,700.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Apellis Stock Forecast & Price Target

Apellis Stock Price Forecast

The average stock forecast for Apellis Pharmaceuticals Inc (APLS) in the next 12 months is 39.38 USD. This price target corresponds to an upside of -4.01%. The range of stock forecasts for Apellis is 21.21 - 47.25 USD. Based on the ratings of 27 analysts, the consensus recommendation for Apellis is HOLD.
Target Low Average Median High
Price (USD) 21.21 39.38 41.82 47.25
Upside -48.31% -4.01% 1.93% 15.16%

Recommendation Trends

The latest consensus rating for Apellis is "HOLD". This is the average recommendation of 27 analysts: 0 strong sell, 0 sell, 19 hold, 5 buy, 3 strong buy. In the previous period, 27 analysts also majorly recommmended "HOLD" for Apellis.

Apellis Financial Stock Forecast

Revenue This Year
0.88B
-12.56%
from 1.00B
Revenue Next Year
1.05B
19.40%
from 0.88B
EPS This Year
-1.20
-775.37%
from 0.18
EPS Next Year
-0.32
-73.45%
from -1.20